Profile | GDS4284 / 243989_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 154.529 | 45 |
GSM687648 | Patient 402 control | 169.523 | 46 |
GSM687653 | Patient 403 control | 136.501 | 42 |
GSM687658 | Patient 404 control | 204.691 | 49 |
GSM687663 | Patient 411 control | 241.262 | 51 |
GSM687668 | Patient 422 control | 179.251 | 47 |
GSM687673 | Patient 424 control | 190.168 | 46 |
GSM687678 | Patient 425 control | 107.246 | 34 |
GSM687683 | Patient 427 control | 247.996 | 50 |
GSM687688 | Patient 428 control | 169.85 | 45 |
GSM687695 | Patient 441 control | 318.378 | 51 |
GSM687699 | Patient 443 control | 207.742 | 46 |
GSM687704 | Patient 444 control | 227.328 | 51 |
GSM687707 | Patient 448 control | 173.718 | 41 |
GSM687712 | Patient 449 control | 214.459 | 49 |
GSM687719 | Patient 450 control | 130.79 | 36 |
GSM687724 | Patient 451 control | 117.6 | 34 |
GSM687728 | Patient 452 control | 173.151 | 44 |
GSM687646 | Patient 401 treated 24h | 193.418 | 47 |
GSM687649 | Patient 402 treated 24h | 179.973 | 48 |
GSM687665 | Patient 411 treated 24h | 231.782 | 49 |
GSM687651 | Patient 402 treated 4 weeks | 157.385 | 42 |
GSM687667 | Patient 411 treated 4 weeks | 206.609 | 49 |
GSM687670 | Patient 422 treated 24h | 202.894 | 47 |
GSM687671 | Patient 422 treated 4 weeks | 141.722 | 42 |
GSM687654 | Patient 403 treated 24h | 147.969 | 44 |
GSM687675 | Patient 424 treated 24h | 153.24 | 41 |
GSM687685 | Patient 427 treated 24h | 222.242 | 50 |
GSM687656 | Patient 403 treated 4 weeks | 135.224 | 43 |
GSM687677 | Patient 424 treated 4 weeks | 133.505 | 40 |
GSM687687 | Patient 427 treated 4 weeks | 96.693 | 36 |
GSM687692 | Patient 428 treated 4h | 183.139 | 46 |
GSM687716 | Patient 449 treated 4h | 200.711 | 49 |
GSM687722 | Patient 450 treated 4h | 246.238 | 49 |
GSM687680 | Patient 425 treated 24h | 235.694 | 51 |
GSM687690 | Patient 428 treated 24h | 226.085 | 52 |
GSM687700 | Patient 443 treated 24h | 285.872 | 49 |
GSM687705 | Patient 444 treated 24h | 206.817 | 50 |
GSM687714 | Patient 449 treated 24h | 144.062 | 43 |
GSM687721 | Patient 450 treated 24h | 233.822 | 47 |
GSM687682 | Patient 425 treated 4 weeks | 171.662 | 46 |
GSM687694 | Patient 428 treated 4 weeks | 83.0257 | 33 |
GSM687702 | Patient 443 treated 4 weeks | 210.532 | 47 |
GSM687718 | Patient 449 treated 4 weeks | 120.762 | 38 |
GSM687723 | Patient 450 treated 4 weeks | 171.661 | 44 |
GSM687661 | Patient 404 treated 4h | 181.007 | 45 |
GSM687710 | Patient 448 treated 4h | 248.64 | 53 |
GSM687726 | Patient 451 treated 4h | 245.609 | 50 |
GSM687730 | Patient 452 treated 4h | 707.337 | 66 |
GSM687660 | Patient 404 treated 24h | 264.877 | 51 |
GSM687697 | Patient 441 treated 24h | 272.472 | 49 |
GSM687709 | Patient 448 treated 24h | 234.39 | 50 |
GSM687725 | Patient 451 treated 24h | 258.511 | 50 |
GSM687729 | Patient 452 treated 24h | 350.691 | 56 |
GSM687727 | Patient 451 treated 4 weeks | 296.505 | 54 |
GSM687731 | Patient 452 treated 4 weeks | 251.096 | 51 |